Nothing Special   »   [go: up one dir, main page]

PL378806A1 - Leczniczy plaster z polisiloksanową matrycą zawierający kapsaicynę - Google Patents

Leczniczy plaster z polisiloksanową matrycą zawierający kapsaicynę

Info

Publication number
PL378806A1
PL378806A1 PL378806A PL37880603A PL378806A1 PL 378806 A1 PL378806 A1 PL 378806A1 PL 378806 A PL378806 A PL 378806A PL 37880603 A PL37880603 A PL 37880603A PL 378806 A1 PL378806 A1 PL 378806A1
Authority
PL
Poland
Prior art keywords
therapeutic compound
capsaicin
therapeutic patch
polysiloxane matrix
concentration
Prior art date
Application number
PL378806A
Other languages
English (en)
Other versions
PL219512B1 (pl
Inventor
Walter Müller
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of PL378806A1 publication Critical patent/PL378806A1/pl
Publication of PL219512B1 publication Critical patent/PL219512B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10—Methods of surface bonding and/or assembly therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL378806A 2003-04-14 2003-11-19 Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego PL219512B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46263003P 2003-04-14 2003-04-14

Publications (2)

Publication Number Publication Date
PL378806A1 true PL378806A1 (pl) 2006-05-15
PL219512B1 PL219512B1 (pl) 2015-05-29

Family

ID=33159857

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378806A PL219512B1 (pl) 2003-04-14 2003-11-19 Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego

Country Status (24)

Country Link
US (2) US8821920B2 (pl)
EP (1) EP1613297B1 (pl)
JP (1) JP4943657B2 (pl)
KR (1) KR101050672B1 (pl)
CN (2) CN100512806C (pl)
AT (1) ATE363900T1 (pl)
AU (1) AU2003289710B2 (pl)
BR (1) BRPI0318250B8 (pl)
CA (1) CA2517493C (pl)
CY (1) CY1106744T1 (pl)
DE (1) DE60314298T2 (pl)
DK (1) DK1613297T3 (pl)
ES (1) ES2288222T3 (pl)
HK (2) HK1090844A1 (pl)
IL (1) IL171249A (pl)
MX (1) MXPA05011012A (pl)
NO (1) NO337896B1 (pl)
NZ (1) NZ541956A (pl)
PL (1) PL219512B1 (pl)
PT (1) PT1613297E (pl)
RU (1) RU2349315C9 (pl)
UA (1) UA81665C2 (pl)
WO (1) WO2004089361A1 (pl)
ZA (1) ZA200506462B (pl)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA012599B1 (ru) 2003-04-10 2009-10-30 Ньюроджескс, Инк. Способы и композиции для введения агонистов trpv1
DE102004044578A1 (de) * 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
WO2006089012A2 (en) * 2005-02-14 2006-08-24 Neurogesx, Inc. Device for delivery of trpv1 agonists
US20060222690A1 (en) * 2005-03-30 2006-10-05 Bley Keith R Low-concentration capsaicin patch and methods for treating neuropathic pain
JP4505644B2 (ja) * 2006-02-17 2010-07-21 フジコピアン株式会社 固定シート
JP4505645B2 (ja) * 2006-02-17 2010-07-21 フジコピアン株式会社 固定シートの貼付方法
JP4505646B2 (ja) * 2006-02-20 2010-07-21 フジコピアン株式会社 固定シート
JP4505649B2 (ja) * 2006-03-23 2010-07-21 フジコピアン株式会社 固定シート
JP2007284370A (ja) * 2006-04-14 2007-11-01 Alcare Co Ltd 体表面用貼付材
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
KR101000945B1 (ko) * 2007-06-08 2010-12-13 주식회사 삼양사 매트릭스형 경피투여제 및 이의 제조방법
US9931241B2 (en) * 2010-06-09 2018-04-03 Kao Corporation Steam-generative warming device
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
KR20150129733A (ko) * 2013-03-14 2015-11-20 알러간, 인코포레이티드 비마토프로스트를 포함하는 국소 조성물 및 이를 사용하여 모발 성장을 자극하는 방법
US20160008294A1 (en) * 2013-06-04 2016-01-14 Purdue Pharma L.P. Transdermal delivery system
ES2694662T3 (es) 2013-07-03 2018-12-26 Lts Lohmann Therapie-Systeme Ag Sistema terapéutico transdérmico con componente electrónico
CN104586818A (zh) * 2013-11-01 2015-05-06 北京中卫神农慢性病医学研究院有限公司 辣椒碱微孔久释器材
KR101574760B1 (ko) * 2013-11-13 2015-12-04 주식회사 엘지생활건강 흡수속도를 개선한 마이크로니들 시스템
CA2948219C (en) 2014-05-20 2023-04-04 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
JP6573913B2 (ja) 2014-05-20 2019-09-11 エルテーエス ローマン テラピー−ジステーメ アーゲー ロチゴチンを含む経皮送達システム
EP4238580A3 (en) * 2014-05-20 2023-10-25 LTS Lohmann Therapie-Systeme AG Transdermal delivery system including an interface mediator
MA40998A (fr) 2014-11-21 2017-09-26 Ophirex Inc Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés
CN104546805A (zh) * 2014-12-15 2015-04-29 刘闯 一种治疗皮肤色斑的药膏贴
EP3266472A1 (en) * 2016-07-08 2018-01-10 Mölnlycke Health Care AB A medical dressing comprising a carrier and a composite material
KR101880442B1 (ko) * 2017-02-02 2018-07-23 대구한의대학교산학협력단 혈압 강하용 패치 조성물
EP3678646B1 (en) * 2017-09-04 2021-09-29 LTS Lohmann Therapie-Systeme AG Transdermal delivery system including an emulsifier
EP4121027A1 (en) 2020-03-17 2023-01-25 Grünenthal GmbH Repeated topical application of capsaicin patch for treating initial non-responders
JP2023520024A (ja) 2020-04-03 2023-05-15 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング カプサイシンパッチの繰り返しの局所適用のためのレジメン
TWI807338B (zh) * 2020-06-26 2023-07-01 美商美國禮來大藥廠 結合ＴＧＦ-α及表皮調節素（ＥＰＩＲＥＧＵＬＩＮ）之抗體於治療疼痛之用途
US11234947B2 (en) * 2020-06-30 2022-02-01 Imperial College Innovations Limited Treatment of peripheral neuropathy induced by cancer chemotherapy
JP2024501004A (ja) * 2020-12-30 2024-01-10 エルケム・シリコーンズ・シャンハイ・カンパニー・リミテッド カプサイシン含有シリコーンゲルでコーティングされたパッチ
WO2024189202A1 (en) * 2023-03-15 2024-09-19 Lts Lohmann Therapie-Systeme Ag Medical patch comprising capsaicin
WO2024189213A1 (en) * 2023-03-15 2024-09-19 Lts Lohmann Therapie-Systeme Ag Medical patch comprising skin irritating active agent

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946106A (en) 1974-10-24 1976-03-23 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4053580A (en) 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
US5145682A (en) 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
GB8704755D0 (en) 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
CN1037242C (zh) * 1994-04-22 1998-02-04 天津轻工业学院 以干红辣椒为原料制备辣椒碱的方法
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
US5762963A (en) 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
GB2340751B (en) * 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
CA2267049A1 (en) 1999-02-05 2000-08-05 Bioglan Laboratories Ltd. Pharmaceutical compositions
DE19923427A1 (de) * 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
DE19958554C2 (de) * 1999-07-02 2002-06-13 Lohmann Therapie Syst Lts Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung
EP1191927B1 (de) * 1999-07-02 2003-03-12 LTS Lohmann Therapie-Systeme AG Mikroreservoirsystem auf basis von polysiloxanen und ambiphilen lösemitteln
US6348501B1 (en) * 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
DE10114382A1 (de) 2001-03-23 2002-09-26 Beiersdorf Ag Feuchtigkeitsaufnehmende Matrix auf Silikonbasis insbesondere zur Wundversorgung und/oder pharmazeutisch/kosmetischen Hautbehandlung
JP3989188B2 (ja) 2001-04-27 2007-10-10 クリストファー・エム・キム 蜂針を用いない蜂毒療法
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
US7063860B2 (en) * 2001-08-13 2006-06-20 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
WO2003015678A1 (en) * 2001-08-17 2003-02-27 Lavipharm Laboratories Inc. Composition and transdermal drug delivery device
US8246979B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine

Also Published As

Publication number Publication date
CN1784222A (zh) 2006-06-07
AU2003289710A1 (en) 2004-11-01
KR20060002997A (ko) 2006-01-09
JP2006514977A (ja) 2006-05-18
AU2003289710B2 (en) 2009-07-30
ATE363900T1 (de) 2007-06-15
WO2004089361A1 (en) 2004-10-21
HK1090844A1 (en) 2007-01-05
US8821920B2 (en) 2014-09-02
RU2349315C2 (ru) 2009-03-20
RU2349315C9 (ru) 2010-02-27
JP4943657B2 (ja) 2012-05-30
HK1136957A1 (en) 2010-07-16
RU2005134984A (ru) 2007-05-27
BRPI0318250B1 (pt) 2015-08-11
UA81665C2 (ru) 2008-01-25
US20040202707A1 (en) 2004-10-14
CA2517493C (en) 2011-05-31
CN100512806C (zh) 2009-07-15
NO20055310L (no) 2005-11-10
US20140335150A1 (en) 2014-11-13
IL171249A (en) 2010-06-16
ZA200506462B (en) 2006-05-31
NZ541956A (en) 2008-09-26
CN101601664B (zh) 2012-05-23
DK1613297T3 (da) 2007-09-24
EP1613297A1 (en) 2006-01-11
BRPI0318250B8 (pt) 2021-05-25
DE60314298D1 (de) 2007-07-19
EP1613297B1 (en) 2007-06-06
PL219512B1 (pl) 2015-05-29
PT1613297E (pt) 2007-08-23
KR101050672B1 (ko) 2011-07-19
MXPA05011012A (es) 2005-12-12
CA2517493A1 (en) 2004-10-21
DE60314298T2 (de) 2008-01-31
CN101601664A (zh) 2009-12-16
CY1106744T1 (el) 2012-05-23
NO337896B1 (no) 2016-07-04
BR0318250A (pt) 2006-05-23
ES2288222T3 (es) 2008-01-01

Similar Documents

Publication Publication Date Title
HK1090844A1 (en) Therapeutic patch with polysiloxane matrix comprising capsaicin
NO20050472L (no) Forbedret transdermalt leveringssystem for administrering av rotigotin
WO2007038329A3 (en) A patch for treating symptoms of a skin abscess
RU2009123368A (ru) Трансдермальная терапевтическая система для введения активного вещества бупренорфина
WO2007125501A3 (en) Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
GB2459614A (en) Athletic information display
WO2009026178A3 (en) High concentration local anesthetic formulations
WO2007095615A3 (en) Use of benzo-heteroaryl sulfamide derivatives for the treatmentof pain
BRPI0415164A (pt) dispositivo para administrar uma composição bioterapêutica, composição bioterapêutica, método de preparação de uma composição bioterapêutica, método de tratamento, e dispensador
ATE468849T1 (de) Idebenon zur behandlung von muskeldystrophien
DE602004019502D1 (de) Zusammensetzungen zur haarbehandlung
EA201300648A1 (ru) Трансдермальная терапевтическая система (tts), содержащая ротиготин
EP1844779A3 (de) Tergurid/Protergurid zur Behandlung von chronischen Schmerzen (z.B. Migräne)
DK1524971T3 (da) Forbedret transdermalt leveringssystem
BRPI0518000A (pt) tetrahidroisoquinolinas aril- e heteroaril- substituìdas e uso das mesmas para bloquear a reabsorção de norepinefrina, dopamina e serotonina
TW200503788A (en) Percutaneous patch containing tulobuterol
MX2015010967A (es) Formulaciones transdermicas de laquinimod.
JP2003212765A (ja) 水虫の活動を停止させる溶液
DE20221247U1 (de) Transdermal-Pflaster zum Verabreichen von Fentanyl
IL182297A (en) Use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
WO2004083398A3 (en) Therapeutic uses of hmgn1 and hmgn2
JP2009221445A (ja) カツラ用ゴム系接着剤
MX2008006436A (es) Parche para tratar sintomas de un absceso en la piel.
ATE425765T1 (de) Verwendung von kollagen in kombination mit sauerstoff- und ozon-freisetzenden perfluorkohlenwasserstoffen zur herstellung eines medikaments zur behandlung von hautverletzungen
WO2008001085A3 (en) Combined wound plaster and swab